Abstract

This study aims to investigate and evaluate spirulina’s anticancer properties.The current research is centred on obtaining a Spirulina-containing drug. The goal is to design and create Phytosomes, characterizing them based on relevant and crucial parameters. The process of solvent evaporation was utilized in the creation of Phytosomes. Various parameters such as zeta potential, particle size, infra-red spectral analysis, % drug content, encapsulation efficiency, and % drug release (% DR) were evaluated. The optimized batch SP2 exhibited a zeta potential of -30.2mV and an average particle size of 554.2 nm is considered well-accepted and suitable due to its significant drug release. Notably, the In-Vitro drug release at the 12th hour and % Encapsulation efficiency of the optimized batch SP2 were reported as 90.87% and 90.42%, respectively. The optimized batch (SP2) underwent stability studies and In-Vitro anticancer assessments, confirming its acceptance, suitability, palatability, ease of administration, and overall elegance.

Keyworde: Spirulina, Solvent Evaporation Method, Phytosomes, Optimization, Anticancer activity, stability study.

Full Text PDF

Refrences:

1. Doroshow JH. Redox modulation of chemotherapy-induced tumor cell killing and normal tissue
toxicity. Journal of the National Cancer Institute. 2006 Feb 15;98(4):223-5.
2. Rhee SG. H2O2, a necessary evil for cell signaling. Science. 2006 Jun 30;312(5782):1882-3.
3. Ferreira DD, Lopes SC, Franco MS, Oliveira MC. pH-sensitive liposomes for drug delivery in
cancer treatment. Therapeutic delivery. 2013 Sep;4(9):1099-123.
4. . Wu W, Luo L, Wang Y, Wu Q, Dai HB, Li JS, Durkan C, Wang N, Wang GX. Endogenous pH-
responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging
applications. Theranostics. 2018;8(11):3038.
5. Lu M, Qiu Q, Luo X, Liu X, Sun J, Wang C, Lin X, Deng Y, Song Y. Phyto-phospholipid
complexes (phytosomes): A novel strategy to improve the bioavailability of active constituents.
Asian journal of pharmaceutical sciences. 2019 May 1;14(3):265-74.
6. Desai K, Sivakami S. Spirulina: The wonder food of the 21st Century. Asia-Pacific Biotech News.
2004 Dec;8(23):1298-302.
7. Capelli B, Cysewski GR. Potential health benefits of spirulina microalgae* A review of the existing
literature. Nutrafoods. 2010 Apr;9(2):19-26.
8. Abu Zaid AA, Hammad DM, Sharaf EM. Antioxidant and anticancer activity of Spirulina platensis
water extracts. International Journal of Pharmacology. 2015 Jan 1;11(7):846-51.
9. Barka A, Amira AB, Francis F, Blecker C. Physicochemical characterization of colored soluble
protein fractions extracted from Spirulina (Spirulina platensis). Food Science and Technology
International. 2018 Dec;24(8):651-63.
10. Czerwonka A, Kaławaj K, Sławińska-Brych A, Lemieszek MK, Bartnik M, Wojtanowski KK,
Zdzisińska B, Rzeski W. Anticancer effect of the water extract of a commercial Spirulina
(Arthrospira platensis) product on the human lung cancer A549 cell line. Biomedicine &
Pharmacotherapy. 2018 Oct 1;106:292-302.
11. Gantar M, Dhandayuthapani S, Rathinavelu A. Phycocyanin induces apoptosis and enhances the
effect of topotecan on prostate cell line LNCaP. Journal of medicinal food. 2012 Dec
1;15(12):1091-5.
12. Gantar M, Simović D, Djilas S, Gonzalez WW, Miksovska J. Isolation, characterization and
antioxidative activity of C-phycocyanin from Limnothrix sp. strain 37-2-1. Journal of
biotechnology. 2012 May 31;159(1-2):21-6.
13. Oh SH, Ahn J, Kang DH, Lee HY. The effect of ultrasonificated extracts of Spirulina maxima on
the anticancer activity. Marine Biotechnology. 2011 Apr;13:205-14.
14. Yang F, Tang Q, Zhong X, Bai Y, Chen T, Zhang Y, Li Y, Zheng W. Surface decoration by
Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium
nanoparticles. International Journal of Nanomedicine. 2012 Feb 17:835-44.
15. Lewensohn R, Gullbo J, Larsson R, Ehrsson H, Luthman K, inventors; Oncopeptides AB, assignee.
Melphalan derivatives and their use as cancer chemotherapeutic drugs. United States patent US
6,992,207. 2006 Jan 31.
16. Mundy GR, Garrett IR, Rossini JG, inventors; OsteoScreen Inc, assignee. Inhibitors of proteasomal
activity for stimulating bone growth. United States patent US 6,838,436. 2005 Jan 4.